1
|
Jensen MLV, Aabenhus RM, Holzknecht BJ, Bjerrum L, Siersma V, COrdoba G, Jensen JN. Sociodemographic characterisation of antibiotic heavy users in the Danish elderly population. Scand J Public Health 2024; 52:31-38. [PMID: 36076357 DOI: 10.1177/14034948221119638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
AIMS The development of effective interventions to reduce inappropriate use of antibiotics in the elderly population requires knowledge on who can benefit from such interventions. Thus, we aimed to identify and characterise antibiotic heavy users among elderly patients in general practice with respect to sociodemographic variables. METHODS We conducted a retrospective nationwide register-based study on all Danish elderly citizens (⩾65 years) who redeemed an antibiotic prescription in 2017. Heavy users were defined as the 10% with the highest excess use, that is, their recorded use minus the average use for their sex, age group and comorbidity level as estimated from a linear regression model. Comparative analyses of sociodemographic characteristics (civil status, employment status, urbanity, educational level and country of origin) of heavy users and non-heavy users were performed using logistic regression models. RESULTS The study population consisted of 251,733 elderly individuals, who in total redeemed 573,265 prescriptions of antibiotics. Heavy users accounted for 68% of all excess use of antibiotics. In multivariable analyses, individuals with an educational level above basic schooling, non-retired, residing in an urban municipality and being born in a country outside Scandinavia all had lower odds of being a heavy user. Widowed, divorced or single individuals had higher odds of being a heavy user compared with married individuals. Relative importance analyses showed that civil status and educational level contributed considerably to the explained variance. CONCLUSIONS This study found an association between sociodemographic characteristics and risk of being a heavy user, indicating that sociodemographic variation exists with regard to antibiotic prescribing.
Collapse
Affiliation(s)
- Maria L V Jensen
- Department of Clinical Microbiology, Copenhagen University Hospital - Herlev and Gentofte, Denmark
- The Research Unit for General Practice and Section of General Practice, University of Copenhagen, Denmark
| | - Rune M Aabenhus
- The Research Unit for General Practice and Section of General Practice, University of Copenhagen, Denmark
| | - Barbara J Holzknecht
- Department of Clinical Microbiology, Copenhagen University Hospital - Herlev and Gentofte, Denmark
- Department of Clinical Medicine, University of Copenhagen, Denmark
| | - Lars Bjerrum
- The Research Unit for General Practice and Section of General Practice, University of Copenhagen, Denmark
| | - Volkert Siersma
- The Research Unit for General Practice and Section of General Practice, University of Copenhagen, Denmark
| | - Gloria COrdoba
- The Research Unit for General Practice and Section of General Practice, University of Copenhagen, Denmark
| | - Jette N Jensen
- Department of Clinical Microbiology, Copenhagen University Hospital - Herlev and Gentofte, Denmark
- Capital Region Committee for the Prevention of Hospital Infections, Copenhagen, Denmark
| |
Collapse
|
2
|
Lee S, Datta R. Frontiers in antimicrobial stewardship: antimicrobial use during end-of-life care. ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY : ASHE 2023; 3:e164. [PMID: 38028928 PMCID: PMC10644156 DOI: 10.1017/ash.2023.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Revised: 06/01/2023] [Accepted: 06/02/2023] [Indexed: 12/01/2023]
Affiliation(s)
- Seohyuk Lee
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
| | - Rupak Datta
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA
| |
Collapse
|
3
|
Kim JH, Yoo SH, Keam B, Heo DS. The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study. J Antimicrob Chemother 2022; 78:302-308. [PMID: 36424671 DOI: 10.1093/jac/dkac405] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2022] [Accepted: 11/08/2022] [Indexed: 11/26/2022] Open
Abstract
OBJECTIVES A substantial number of hospitalized patients with terminal cancer at the end-of-life phase receive antibiotics, even with imminent death. We evaluated the impact of palliative care consultation on antibiotic use in hospitalized patients with terminal cancer during the end-of-life phase. METHODS We identified adult patients with metastatic solid cancer who died at a tertiary medical centre in Seoul, Republic of Korea, following at least 4 days of hospitalization (January 2018-December 2020). Patients were divided into palliative and non-palliative care consultation groups. Propensity score-weighted, multivariable logistic regression analysis was used to compare the proportion of patients receiving antibiotics within 3 days before death between the two groups. RESULTS Among 1143 patients analysed, 940 (82.2%) received antibiotics within 3 days before death. The proportion of patients receiving antibiotics was significantly lower (propensity score-weighted P < 0.001) in the palliative care consultation group (344/468; 73.5%) than in the non-palliative care consultation group (596/675; 88.3%). The decrease in the proportion of patients receiving antibiotics in the palliative care consultation group was significant for a carbapenem (42.4% versus 22.4%; P < 0.001), a glycopeptide (23.3% versus 11.1%; P < 0.001) and a quinolone (30.5% versus 19.4%; P = 0.012). In the multivariable logistic regression analysis, receiving palliative care consultation (adjusted OR 0.46, 95% CI 0.33-0.65; P < 0.001) was independently associated with reduced antibiotic use during the end-of-life phase. CONCLUSIONS Palliative care consultation may reduce aggressive antibiotic use in hospitalized patients with terminal cancer during the end-of-life phase.
Collapse
Affiliation(s)
- Jeong-Han Kim
- Division of Infectious Diseases, Department of Internal Medicine, Ewha Woman University College of Medicine, Seoul Hospital, Seoul, Republic of Korea
| | - Shin Hye Yoo
- Center for Palliative Care and Clinical Ethics, Seoul National University Hospital, Seoul, Republic of Korea
| | - Bhumsuk Keam
- Center for Palliative Care and Clinical Ethics, Seoul National University Hospital, Seoul, Republic of Korea.,Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Dae Seog Heo
- Patient-Centered Clinical Research Coordinating Center, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea
| |
Collapse
|
4
|
Seaton RA, Cooper L, Gibbons CL, Malcolm W, Choo-Kang B, Griffith D, Dundas S, Brittain S, Hamilton K, Jeffreys D, McKinney R, Guthrie D, Sneddon J. Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals. JAC Antimicrob Resist 2021; 3:dlab078. [PMID: 34223137 PMCID: PMC8211567 DOI: 10.1093/jacamr/dlab078] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Accepted: 04/30/2021] [Indexed: 01/08/2023] Open
Abstract
Background Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. Objectives To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. Methods An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical areas (including critical care) in 15 Scottish hospitals. Antibiotics prescribed for RTI and factors associated with prescribing were investigated. Results Of 820 surveyed patients, 272 (prevalence 33.3%) received antibiotics for suspected RTI on the survey day and 58.8% were SARS-CoV-2 positive. Antibiotics were empirical in 91.9% and amoxicillin (24.6%), doxycycline (20.5%) and co-amoxiclav (15%) were most frequently prescribed. Oral antibiotics were prescribed in 54.5% and duration was recorded in 76.7% on wards for a median of 5 days. IV to oral switch occurred after a median of 2 days. Prescribing for RTI was independently and positively associated with COPD/chronic lung disease, purulent/bloody sputum, abnormal chest X-ray, and CRP ≥ 100 mg/L. Probable and definite hospital-acquired COVID-19 and diabetes were associated with a lower odds of receiving an antibiotic for RTI. Conclusions Antibiotic prescribing for suspected RTI was commonly observed and predominantly empirical in suspected or proven COVID-19. Initiatives to reinforce stewardship principles including clinical review, effective use of microbiological diagnostics and better understanding of the role of biomarkers are central to further limit unnecessary antibiotic therapy in COVID-19.
Collapse
Affiliation(s)
- R Andrew Seaton
- Infectious Diseases Unit, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK.,Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow, G1 2NP, UK
| | - Lesley Cooper
- Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow, G1 2NP, UK
| | - Cheryl L Gibbons
- Public Health Scotland, NHS National Services Scotland, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, UK
| | - William Malcolm
- ARHAI Scotland, NHS National Services Scotland, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, UK
| | - Brian Choo-Kang
- Respiratory Medicine Unit, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, UK
| | - David Griffith
- Department of Microbiology, Victoria Infirmary, Hayfield Road, Kirkcaldy, KY2 5AH, UK
| | - Stephanie Dundas
- Infection Unit, University Hospital Monklands, Monkscourt Avenue, Airdrie, ML6 OJS, UK
| | - Suzanne Brittain
- Antimicrobial Management Team, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill Road, Aberdeen, AB25 2ZN, UK
| | - Kayleigh Hamilton
- Antimicrobial Management Team, University Hospital Crosshouse, Kilmarnock Road, Crosshouse, Kilmarnock, KA2 0BE, UK
| | - Danielle Jeffreys
- Respiratory Medicine Unit, Raigmore Hospital, Old Perth Road, Inverness, IV2 3UJ
| | - Rachel McKinney
- Regional Infectious Diseases Unit, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU, UK
| | - Debbie Guthrie
- Pharmacy Department, Ninewells Hospital, James Arrott Drive, Dundee, DD2 1SG, UK
| | - Jacqueline Sneddon
- Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow, G1 2NP, UK
| |
Collapse
|